Hypersensitivity, Immediate
22
2
2
17
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Low Risk
Score: 27/100
0.0%
0 terminated out of 22 trials
100.0%
+13.5% vs benchmark
14%
3 trials in Phase 3/4
41%
7 of 17 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 17 completed trials
Clinical Trials (22)
Pathogenesis of Physical Induced Urticarial Syndromes
Head-to-Head Comparison Study Between Different FDA Registered Allergy Skin Test Applicators
Effect of Benralizumab in Atopic Dermatitis
Risk-stratified Testing for Safe Removal of Penicillin Allergy Labels
Repertoire and Properties of Anti-drug Antibodies Involved in Immediate Hypersensitivity in the Operating Room
Assessment of Er:YAG Laser for the Control of Hypersensitivity During Tooth Whitening With Hydrogen Peroxide
Norwegian Birch Rust Allergy Study
The Use of Penicillin Allergy Clinical Decision Rule to Enable Direct Oral Penicillin Challenge
Study to Evaluate Tezepelumab on Airway Inflammation in Adults With Uncontrolled Asthma (CASCADE)
Study to Investigate Efficacy and Safety of PF-04965842 in Subjects Aged 12 Years and Over With Moderate to Severe Atopic Dermatitis With the Option of Rescue Treatment in Flaring Subjects
Asthma Data Innovation Demonstration Project
Tromsø Birch Rust Allergy Study. Allergy to Birch Rust, a Possible Explanation to Seasonal Airway Allergy During Autumn?
Study Evaluating Efficacy and Safety of PF-04965842 and Dupilumab in Adult Subjects With Moderate to Severe Atopic Dermatitis on Background Topical Therapy
Clinical Determinants and Perioperative Allergic Reactions (CADECAP Study)
The Significance of Blood-tryptase and c-Kit Mutation in Insect Venom Immunotherapy
Efficacy and Safety of Dupilumab in Participants ≥12 to <18 Years of Age, With Moderate-to-severe Atopic Dermatitis
Peanut Epicutaneous Phase II Immunotherapy Clinical Trial
A Study Comparing the Quality of Life of Patients in the Treatment of Eczema by Pediatric Generalists and Specialists
Cat Pilot Study - Environmental Exposure Chamber (EEC) vs. Nasal Allergen Challenge (NAC)
Clinical and Immunological Evaluation of Children With Allergies